JPIN participates in BioSapien’s USD1.8m investment round
Startup investment bank for the emerging markets JPIN Venture Catalysts (JPIN) has participated in a USD1.8 million investment round in BioSapien, a biotech that uses 3D Printed Biodegradable mesh designed to deliver cancer drugs directly to tumour sites with greater efficacy and reduced side effects.